NCT01475539View on ClinicalTrials.gov

Sequential Inactivated Poliomyelitis Vaccine Followed by Oral Poliomyelitis Vaccine Versus Oral Poliomyelitis Vaccine

PHASE4CompletedINTERVENTIONAL
Enrollment

456

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

May 31, 2013

Study Completion Date

November 30, 2013

Conditions
PolioPoliomyelitis
Interventions
BIOLOGICAL

Injectable inactivated types 1, 2 and 3 poliovirus + Live oral Polio

0.5 mL, Intramuscular + 1g dragee candy oral dose

BIOLOGICAL

Injectable inactivated types 1, 2 and 3 poliovirus + Live oral Polio

0.5 mL, Intramuscular + 1g dragee candy oral dose

BIOLOGICAL

Live oral poliovirus type 1, 2 and 3

1g dragee candy, oral

Trial Locations (1)

530028

Nanning

All Listed Sponsors
lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY

NCT01475539 - Sequential Inactivated Poliomyelitis Vaccine Followed by Oral Poliomyelitis Vaccine Versus Oral Poliomyelitis Vaccine | Biotech Hunter | Biotech Hunter